Chemotactics Inc is categorized under Commercial Biotechnical Research in San Diego, CA and active since 2013.
Chemotactics Inc was established in 2013, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact John Yamauchi at the company’s single location by writing to 7770 Regents Road 113-318, San Diego, California CA 92122 or by phoning (818) 970-3440. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Chemotactics Inc |
Contact Person: | John Yamauchi |
Address: | 7770 Regents Road 113-318, San Diego, California 92122 |
Phone Number: | (818) 970-3440 |
Website Address: | chemotactics.com |
Annual Revenue (USD): | $0 to $49.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Chemotactics Inc was started in 2013 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact John Yamauchi for inquiries that concern Chemotactics Inc by calling the company number (818) 970-3440, as your correspondence is most welcome. Additionally, the physical location of the single location of Chemotactics Inc can be found at the coordinates 32.863258,-117.222777 as well as the street address 7770 Regents Road 113-318 in San Diego, California 92122.
For its online presence, you may visit Chemotactics Inc’s website at chemotactics.com and engage with its social media outlets through on Twitter and on Facebook.